When will Intellia Therapeutics submit a BLA for Lonvo-z?

Prediction market on kalshi. If Intellia Therapeutics, Inc. submits a BLA for Lonvoguran Ziclumeran (lonvo-z) to the FDA before Nov 1, 2026, then the market resolves to Yes.

Liquidity: $898.08. Resolves: 11/8/2026.